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Abstract 
Combining two existing protocols of trangenesis, namely the REMI and the I-SceI meganuclease 
methods, we generated Xenopus leavis expressing a transgene under the control of a promoter that 
presented a restricted pattern of activity and a low level of expression.  This was realized by co-
incubating sperm nuclei, the I-SceI enzyme and the transgene prior to transplantation into 
unfertilized eggs. The addition of the woodchuck hepatitis virus posttranscriptional regulatory 
element (WPRE) in our constructs further enhanced the expression of the transgene without 
affecting the tissue-specificity of the promoter activity. Using this combination of methods we 
produced high rates of fully transgenic animals that stably transmitted the transgene to the next 
generations with a transmission rate of 50% indicating a single integration event. 
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Introduction  
The amphibian Xenopus laevis has played a key role in the study of vertebrate development and the 
establishment of important concepts in developmental biology (for review see Stern 2005; Heasman 
2006). The large size of eggs and embryos permit microsurgical manipulation. It is also possible to 
over-express specific gene products in particular regions of the embryo by micro-injection of 
synthetic mRNA or to inhibit zygotic gene function by the use of dominant negative approach 
(Amaya et al. 1991) or antisense morpholinos (Heasman et al. 2000). 
The ability to generate transgenic Xenopus has reinforced the interest in this model. This was first 
achieved in the late 90’s when Kroll and Amaya (1996) described a method based on the Restriction 
Enzyme Mediated Integration (REMI) developed in Dictyostelium discoideum (Kuspa and Loomis 
1992). According to these authors, the transgene was supposed to integrate in the chromatin-
decondensed sperm nuclei before transplantation in unfertilized eggs. This method was further 
simplified by omitting egg extracts and restriction enzyme to avoid the weakening of decondensed 
sperm nuclei (Sparrow et al. 2000). It enables the production of non mosaic and stable transgenic 
animals. However, one of the major drawbacks is that chromosomal integration occurs as 
concatemers (2 to 6 copies) at 4-8 sites of the genome. 
In 2002, a new approach based on the use of a yeast transposase, the meganuclease I-SceI, was 
proposed to generate transgenic fishes (Thermes et al. 2002). The co-injection in the cytoplasm of 
one-cell stage embryos of the enzyme and a plasmid carrying the transgene flanked by two 
restriction sites for I-SceI allowed the rapid integration of a functional insert. Moreover, in the fish 
species, the observed germline transmission rates were about 50% suggesting a single integration of 
the transgene into one-cell stage embryos. This was confirmed by Southern blot analysis since the 
reporter was found integrated as a single copy or few copies in tandem into mostly single sites 
within the genome (Thermes et al. 2002).   
This transgenesis method using meganuclease has been successfully used in other fish species 
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(zebrafish Danio rerio: Grabher et al. 2004) and the ascidian Ciona savignyi (Deschet et al. 2003).  
More recently, it has been adapted to different amphibian species such as axolotl (Sobkow et al. 
2006) or the anurans Xenopus laevis (Pan et al. 2006) and Xenopus tropicalis (Ogino et al. 2006). 
Contrary to what happens in fishes, transgenic amphibians produced with this method were mainly 
mosaic and only 10 to 15% of developing embryos showed a non-mosaic expression of the 
transgene. The majority of the F0 founders transmitted the transgene to less than 50 % of their 
progeny.  Interestingly, the main advantage of this method, namely the few transgene copy number, 
was preserved in Xenopus. 
Other methods, based on the use of different transposases, were also proposed. However, these 
protocols need the co-injection of the plasmid carrying the transgene and the mRNA encoding the 
transposase. The delay between the injection of mRNA and the production in the cells of the active 
enzyme led to the production of mosaic animals that were of limited use for promoter analysis in 
the F0 founder generation (Allen and Weeks 2005; Hamlet et al. 2006; Sinzelle et al. 2006). 
From all these studies, it seems quite difficult to obtain stable F1 generation which will be useful for 
the amphibian community. Moreover, all the experiments conducted so far have been realised with 
a little number of promoters in combination with GFP. Despite the obvious advantage of GFP to 
monitor expression, the threshold level required for detection makes it inappropriate to assess low 
level of gene expression. 
Using a combination of REMI and I-SceI meganuclease methods we produced high rates of fully 
transgenic Xenopus bearing a few number of transgene copies. We used the promoter of the pan 
neural gene neuro-tubulin (NTub) which has been previously used (Ryffel and Lingott 2000) and 
the promoter of the bHLH neurogenic differentiation factor NeuroD encoding gene which has a low 
and restricted transcriptional activity (Lee et al. 1995). However, this method was not sufficient to 
obtain convincing expression of GFP under the control of the neuroD promoter. This could be 
achieved either by boosting transcription or by acting on post-transcriptional events, which would 
limit the potential alteration of the promoter tissue-specificity. The ability of a post-transcriptional 
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regulatory element from woodchuck hepatitis virus (WPRE) to enhance the expression of a 
transgene in retrovirus (Zufferey et al. 1999) or adenovirus (Glover et al. 2002; Xu et al. 2003) 
vectors without affecting the tissue specificity (Glover et al. 2002) has already been demonstrated. 
However, to date, the efficiency of cis-acting elements such as WPRE has only been assessed in 
mammals or mammalian cell lines and little is known about its ability to enhance the in vivo 
expression of a transgene in a non-mammalian species. Thus, in this work, we also performed 
transgenesis in Xenopus laevis with constructs containing the neuroD promoter, which drives the 
expression of the enhanced green fluorescent protein (EGFP) and the WPRE element, localized in 
the 3'UTR of the EGFP sequence. 
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Methods 
 
Plasmid constructs 
The pEGFP-1 reporter vector (Clontech) was modified by introducing double-strand 
oligonucleotides containing an I-SceI recognition site (Colleaux et al. 1988; Thermes et al. 2002) in 
the Bgl II and Afl II restriction sites to generate pSce-EGFP-Sce. For transgenesis, a 3.8 kb neuro-
tubulin promoter from Xenopus (accession number: EF989124) was inserted in the Hind III site of 
pSce-EGFP-Sce to generate pSce-NBT-EGFP-Sce. A 1.3 kb neuroD promoter fragment (accession 
number: EF591766) was cloned from genomic libraries generated using the Universal Genome 
Walker kit (Clontech) according to the manufacturer's protocol.  Two reporter plasmids were then 
constructed, containing either the entire cloned 5' flanking region (1.3neuroD) or only the 320 bp 
proximal region (0.3neuroD) in the Sac I / Hind III sites of pGL3 reporter plasmid (Promega) to 
perform transfection assays. These constructs were then designated as p0.3neuroD-Luc and 
p1.3neuroD-Luc. An expression vector, pCS-MT-xNGNR-1a, (provided by Dr. D.J. Anderson, 
Howard Hughes Medical Institute, California Institute of Technology, Pasadena, California) was 
used in co-transfection assays to check the ability of the xneuroD promoter fragments to be induced. 
The two fragments of xneuroD promoter were also introduced into the Xho I / Bam HI (0.3neuroD) 
or Sma I (1.3neuroD) restriction sites of pSce-EGFP-Sce for transgenesis. A WPRE element 
(Woodchuck Post-transcriptional Regulatory Element, provided by Pr D. Trono, Geneva, 
Switzerland; accession number: J04514) was inserted in the Xba I site of pGL3, p0.3neuroD-Luc 
and p1.3neuroD-Luc used in transfection studies or the Not I site of p0.3neuroD-EGFP and 
p1.3neuroD-EGFP used in transgenesis, between the reporter gene and the polyadenylation signal.  
 
Culture of P19 cells and transfection assays 
P19 mouse multipotent embryonic carcinoma cells were grown in DMEM (Dulbecco's Modified 
Eagle Medium, Invitrogen Gibco BRL) supplemented with 10% foetal calf serum (Invitrogen Gibco 
BRL) at 37°C in a humidified 5% CO2 atmosphere. P19 cells were plated at a density of 0.5 x 10
5
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cells per well of 24 well plates (BD Falcon). Cultures were transfected with 400 ng of reporter 
vector (pGl3, pGl3-WPRE, p0.3neuroD-Luc, p0.3neuroD-Luc-WPRE, p1.3neuroD-Luc or 
p1.3neuroD-Luc-WPRE) with or without 50 ng of expression vector (pCS-MT-xNGNR-1a) using 
the calcium phosphate transfection method (Wigler et al. 1978). All transfections were achieved 
with 100 ng of an internal control vector (pCH110, Amersham Pharmacia Biotech). The total 
amount of DNA was supplemented at 1 µg per transfected well with the addition of pBluescript 
plasmid. During the transfection step, cells were grown at 37°C in a humidified 2% CO2 
atmosphere. Luciferase activity was assayed 45 hours after transfection using the luciferase assay 
system according to the manufacturer’s protocol (Promega) and normalized with the β-
Galactosidase activity (Sambrook et al. 1989). Each experiment was performed at least four times in 
triplicates.  
 
Embryo manipulation and microinjection of transgenes 
The use of the I-SceI meganuclease was combined with the method based on the transplantation of 
purified sperm nuclei (Sparrow et al. 2000). The sperm nuclei were prepared according to the 
protocol described by Kroll and Amaya (1996). For transgenesis, 500 ng of plasmid vectors were 
digested for 30 min at room temperature with I-SceI meganuclease (Roche Applied Science) in the 
appropriate buffer and then combined with 500 000 sperm nuclei and incubated for 5 minutes at 
room temperature. The reaction was diluted in 200 µl of MOH injection buffer (KPO4 10 mM, 
Kgluconate 125 mM, NaCl 5 mM, MgCl2 0.5 mM, Sucrose 250 mM, Spermidine 0.25 mM and 
Spermine 0.125 mM, pH 7.2; Offield et al. 2000) and back filled into glass needles. Unfertilized 
eggs were dejellied using 1.5% cysteine in 0.1×MMR (Marc’s Modified Ringers: Sive et al. 2000), 
rinsed in 0.1×MMR and loaded into the square well of agarose dishes containing 6% Ficoll in 
0.1×MMR at 16°C. The injection was performed using a Harvard 22 syringe pump (Harvard 
Instruments) with a flow rate of 0.6 µl/min. 
A few hours after injection, embryos were transferred into 0.1×MMR without Ficoll and incubated 
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at 19-20°C. Developing embryos were staged according to Nieuwkoop and Faber (1967).  
 
Genomic PCR and Southern blot hybridization 
Genomic DNA was extracted from F1 0.3neuroD-EGFP-WPRE positive or negative tadpoles. 20 ng 
were used for genomic PCR reactions. A part of the transgene was amplified using the following 
primer set:  xNDfor (5’ TCCgCAgAAAgCACCACT 3’) and EGFPrev (5’ 
TTgTCgggCAgCAgCACgg 3’). The PCR cycle conditions were 4 min at 94°C followed by 35 
cycles of 20 sec at 94°C, 20 sec at 58°C, 45 sec at 72°C and a final extension 7 min at 72°C. PCR 
products were separated on a 0.8% agarose gel. 
For the Southern blot analysis, 25 µg of DNA was digested with either BsrG I or Bam HI, separated 
on a 0.8% agarose gel and transferred to a Hybond-N hybridization membrane (Amersham). 
Hybridization was performed with a 800 bp EGFP cDNA probe labeled with [32P]-dCTP . 
 
In situ hybridisation on tissue sections 
Larvae were fixed overnight at 4% (v/v) formaldehyde and processed for in situ hybridisation as 
previously described (Coumailleau and Duprez 2009). Antisense RNA probes were labelled with 
digoxygenin according to manufacturer’s instructions (Roche Diagnostics). The probes were 
detected by an alkaline phosphatase-coupled antibody against digoxygenin using nitroblue 
tetrazolium/5-bromo-chloro-3-indolyl phosphate (NBT/BCIP) as the chromogenic substrate for 
alkaline phosphatase. Antisense NeuroD RNA probes were prepared as previously described (Lee et 
al. 1995). Antisense EGFP was produced using a TOPO/EGFP plasmid generated by subcloning a 
PCR product corresponding to the entire EGFP into the pCR2.1-TOPO plasmid (InVitrogen).  
 
Photomicroscopy 
Images of living transgenic animals were obtained using either a Leica MZF LIII stereomicroscope 
and a Leica DC300F digital camera or an inverted Leica TCS SP2 laser scanning confocal 
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microscope (PIXEL platform of GIS Europia, Rennes). Confocal imaging was performed using a 
HC PL APO 10x (NA=0.40) objective together with a S23 (NA=0.53) condenser. Excitation was 
provided by the 488 nm laser line of Ar laser source. 
 
Image and statistical analysis 
After collection, data were analyzed with the open source software ImageJ 
(http://rsb.info.nih.gov/ij/). The stacks were then projected along the z-axis to give the best 
overview of the structure. The data obtained from transfected P19 cells were analyzed using the 
Student’s t-test. 
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Results 
 
Generation of transgenic Xenopus using a new combination of transgenesis procedures  
Our aim was to obtain transgenic animals carrying a few number of transgene copies. In this 
purpose, we chose a method combining the simplified version of the REMI protocol (Sparrow et al. 
2000) and the Meganuclease-based method (Thermes et al. 2002; Pan et al. 2006). First attempts 
were performed with the construct pSce-NTub-EGFP-Sce based on the promoter of a class II-
Tubuline (Neuro-Tubuline) that is specifically and strongly expressed in the neurons of Xenopus 
embryos (Moody et al. 1996). Using this construct, the EGFP fluorescence was detected in the 
neural tube of embryos from stage 17-18 (Fig. 1A). At tailbud stage, the spinal cord and developing 
brain were fluorescent (Fig. 1B). On later stage, EGFP expression was localized in the nervous 
system. The fluorescence was easily detected in the brain, spinal cord, retina, optic and olfactory 
nerves and olfactory epithelia (Fig. 1C). At stage 55, it was still detectable in the nerves of head, 
tail myotomes and limbs (Fig. 1D,E,F).  
Of 5588 injected eggs, 142 (2.5%) developed normally to stage 40. Among these, 41 showed a 
strong and uniform expression in the central nervous system (CNS). 37 embryos expressed EGFP in 
the CNS as well as in various other tissues and 10 others expressed EGFP only outside of the CNS. 
This ectopic expression varied between the embryos in term of localization or intensity. One 
embryo uniformly expressed EGFP in only one half of his CNS reflecting a possible integration of 
the transgene after the first cellular division (Table 1).  
Seven NTub-EGFP founders, presenting a specific expression in CNS, were raised to sexual 
maturity and mated to wild-type animals and germline transmission rates were estimated by scoring 
EGFP expression (Table 2). One of these founders transmitted the transgene to 71% of its progeny, 
probably reflecting the existence of two integration sites. For another one, the transgene was not 
transmitted to the offspring suggesting either the absence of transgene integration or an integration 
that occurred after the differentiation of the germ cell precursors. However, five of these founders 
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produced offspring with 48 to 58% of F1 animals expressing EGFP in the correct tissues. These 
rates are close to the Mendelian ratio for the transmission of a single locus to the offspring. This 
single integration event was confirmed on one of these lines by the sequence analysis of the 
integration site (data not shown).  F2 embryos were also generated from this transgenic line. The 
transmission rate of the transgene was still about 50% in these animals indicating that the transgene 
is stably transmitted in the successive generations (Table 2).  
 
Improvment of reporter gene expression from the xneuroD promoter by the addition of 
WPRE element  
The use of weak promoter is often limited in transgenesis by the fact that their activity is hardly 
detectable. Thus we tried to improve our transgenesis method by integrating a viral element in our 
construct. As a weak promoter, we choose that of the Xenopus neurogenic differentiation factor 
neuroD gene which shows low level and restricted patterns of expression (Lee et al. 1995). 
Using PCR on a Xenopus laevis genomic library, we generated a 2.4 kb DNA fragment containing a 
part of the xneuroD gene (accession number: EF591766). Determination of the transcription start 
site by RACE PCR and comparison with human (Miyachi et al. 1999) and mouse (Xu and Murphy 
1998) neuroD genes showed that this fragment comprises about 1.3 kb of the 5’ flanking region of 
this gene (data not shown). 
The transcriptional activity of this neuroD promoter was assayed in transiently transfected mouse 
P19 cells. Luciferase reporter plasmids containing two fragments of the neuroD promoter region, 
termed 0.3neuroD and 1.3neuroD, were transiently transfected in mouse P19 stem cells to assess 
their transcriptional activities. These two fragments contained the three E-boxes involved in neuroD 
transcription activation (Miyachi et al. 1999; Huang et al. 2000).  As shown in Fig. 2 A, the relative 
luciferase activities of p0.3neuroD-Luc and p1.3neuroD-Luc were found to be 5 to 10-fold higher 
than that of pGL3. The basal activity of p0.3neuroD-Luc was 1.8 to 2-fold above p1.3neuroD-Luc 
activity (p<0.01).  In the P19 cells, it is known that the basal activity of neuroD promoter is very 
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low (Itoh et al. 1997; Kim et al. 2004) but can be strongly induced by another bHLH factor, 
Neurogenin (Ngn) (Kim et al. 2004). Thus, in order to determine the ability of Ngn-1 to enhance the 
activity of the neuroD promoter fragments, P19 cells were co-transfected with a Xenopus 
Neurogenin-related-1 expression vector, pCS2-X-Ngnr-1a. This resulted in a strong increase of both 
0.3neuroD and 1.3neuroD activity (9 and 11.6-fold respectively, p<0.001) (Fig. 2A). 
To increase reporter gene expression both in vitro and in vivo, WPRE was inserted in our plasmid 
constructs downstream of the open reading frame of the reporter gene.  The efficiency of WPRE 
was then assessed after transient transfection of two constructs, p0.3neuroD-Luc-WPRE and 
p1.3neuroD-Luc-WPRE, in P19 cells. Adding WPRE induced a 1.75 and 1.9-fold (n=18, p<0.002) 
increase of the luciferase activity when used with the 0.3neuroD or 1.3neuroD promoter fragments 
respectively, when compared with the same constructs lacking WPRE (Fig. 2B). 
 
Effects of WPRE on transgene expression in vivo 
In order to obtain transgenic embryos, 0.3neuroD and 1.3neuroD promoter fragments were bound to 
EGFP, with or without WPRE, and flanked by an I-SceI recognition site at both extremities.  
At stage 40, 18% of the animals (n=34) expressed EGFP in the eye, brain and spinal cord when 
placed under the control of 0.3neuroD promoter. For 9% of these embryos, the EGFP detection in 
the future nervous system was already possible at stages 18/20. The addition of WPRE to the same 
construct gave 63% of EGFP-expressing animals at stage 40 (n=51), and fluorescence detection 
began earlier at stage 15 for 19% of embryos. At stages 18/20, 35% of neurula embryos were 
labelled in the future nervous system (Table 3). With 1.3neuroD promoter fragment, no expression 
in the nervous system was obtained. However, the addition of WPRE allowed EGFP detection in the 
CNS from stage 33 with p1.3neuroD-EGFP-WPRE construct. At stage 40, EGFP expression was 
localised in the brain and eyes for two of the eight surviving animals (Table 3). No expression was 
observed in the spinal cord contrary to observations with 0.3neuroD promoter fragment.  
 The preservation of tissue and cellular specificity was checked for the 0.3neuroD promoter 
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construct carrying the WPRE using both confocal microscopy on living embryos and in situ 
hybridisation on fixed tissues. At stage 40, confocal microscopy imaging performed on living 
embryos showed EGFP fluorescence in the five encephalic vesicles (telencephalon, diencephalon, 
mesencephalon, metencephalon and myelencephalon as well as in the retina (Fig. 3A) and the 
spinal cord (not shown). At stage 48, the fluorescence level remained elevated in the pallia, the 
cerebellum and the rhombencephalon (Fig. 3B). In order to precisely check the activity of the 
0.3neuroD promoter in transgenic embryos, we performed in situ hybridisation to detect both EGFP 
and endogenous NeuroD transcripts. We showed that EGFP expression was clearly restricted to the 
brain area that expressed the endogenous neuroD gene since both signals are superimposed in the 
cerebellum (Fig.4A,B) and rhombencephalon (Fig. 4C,D). 
NeuroD, also referred as BETA2, is expressed in the pancreas (Naya et al. 1995; Kelly and Melton 
2000). Spectral analysis in confocal microscopy showed that EGFP was expressed in the pancreas 
of transgenic animals (data not shown). However, this fluorescence was quite difficult to observe in 
classical fluorescent microscopy because of the high auto-fluorescence of this tissue. 
Some embryos expressing EGFP under the control of 0.3neuroD promoter from a construct 
containing WPRE element were raised to sexual maturity and used to estimate the transmission rate 
to the F1 offspring. As previously obtained with pSce-NTub-EGFP-Sce, a majority of the founders 
(5 out of 6) transmitted the transgene to about 50% of their progeny (Table 4). Transgene 
integration was analyzed in one of these lines using genomic PCR and Southern blot. Both methods 
showed that EGFP fragments can be detected only in EGFP-positive animals indicating that the 
absence of expression in EGFP-negative animals is not due to transgene silencing (Fig. 5 A,C). 
Moreover, the patterns observed in the Southern blot experiment are consistent with the hypothesis 
of a single integration of the transgene in the host genome. The presence of a weak band of about 2 
kb indicated that the transgene might be inserted as a tandem repeat (Fig 5B,C). Transmission rate 
to the F2 generation was also assessed for one of these transgenic lines and was found to be stable 
between the different generations (Table 4). 
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Discussion 
 
In this study, we showed that the combination of two previously described protocols, namely the 
REMI (Kroll and Amaya 1996) and I-SceI meganuclease (Thermes et al. 2002) methods, allowed 
the obtention of a high rate of fully transgenic animals in the F0 generation with a limited number 
of transgene integration events. This was assessed with different constructs based on the use of 
promoters of two genes, NTubuline and NeuroD, that have different transcriptional activities. 
NTubuline is a class-II tubulin that is specifically and strongly expressed in differentiated 
neurons (Moody et al. 1996) whereas NeuroD is a transcription factor that belongs to the bHLH 
superfamily and promotes the differentiation of neuronal precursor cells in neurons (Lee et al. 
1995). Morevover, this latter gene presents low level and restricted pattern of expression. 
The limitation of integration events was shown by the transmission rates close to 50% obtained 
from a majority of F0 founders and genomic DNA analysis, both indicating an integration in a 
single site of the host genome. In this case, all the siblings obtained from a single founder exhibited 
the same pattern of expression and similar level of fluorescence. This is in contrast with the results 
published by Marsh-Armstrong et al. (1999) reporting that most of the founders produced by the 
REMI method presented 2 to more than 4 integration events which resulted in siblings presenting 
various fluorescence intensities. F2 embryos expressing EGFP were also produced from some F1 
adults mated with wild type animals showing that the transgene is stably integrated in germline 
cells. Moreover, the transgene transmission rate is the same between F1 and F2 generations as 
between F0 and F1. 
Combining the protocols was found to be far more efficient than using the I-SceI meganuclease 
alone in term of transgene transmission between F0 and F1. Indeed, with I-SceI alone, the 
transmission rate rarely reaches 50% whatever the animal species indicating that, in this case, the 
integration into the host genome occurs mainly after the first cellular division (Thermes et al. 2002; 
Deschet et al. 2003; Grabher et al. 2004; Ogino et al. 2006; Pan et al. 2006; Sobkow et al. 2006). It 
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is interesting to note that in our hands this method gave almost the same results (one transgenic line 
with a transmission rate close to 50% on 6 tested, unpublished data).  
The mechanisms involved in the limitation of integration events when I-SceI meganuclease is used 
together with sperm nuclei remain largely unknown. However, it is clear that the incubation of the 
transgene with sperm nuclei promotes its rapid integration in the genome reducing the number of 
embryos presenting a mosaic expression of this transgene. Although this cannot be totally ruled out, 
it is very unlikely that I-SceI facilitates transgene integration by generating double strand breaks 
(DSB) in Xenopus genomic DNA since it has a 18-bp long recognition site and therefore a low 
probability of cutting in the host genome. Another possibility is that the integration happens after 
the introduction of sperm nuclei into the oocyte. In this case, sperm nuclei could only be vectors 
that carry the transgene into the cell and the integration could occur at the time of pronuclei fusion. 
As previously demonstrated, exogenous DNA incubated with sperm cells or purified nuclei is 
rapidly internalized (Francolini et al. 1993) and mature sperm cells can even be used as vectors to 
introduce DNA into eggs and generate transgenic animals (Lavitrano et al. 1989). Whatever the 
precise mechanism involved in the integration, I-SceI could intervene in DSB repair as it apparently 
proceeds in yeast where it promotes intron homing (for review, see Dujon 1989).  
Although it probably needs to be confirmed in various promoter contexts, we showed in this paper 
that WPRE could be useful to enhance transgene expression in Xenopus without affecting its tissue-
specificity. WPRE is a post-transcriptional regulatory element (Donello et al. 1998) that does not 
interfere with the promoter activity and its efficiency was previously demonstrated in different 
tissues using adenovirus vectors (Xu et al. 2003). It probably functions by modifying the RNA poly-
adenylation, export and/or translation (Zufferey et al. 1999; Mastroyiannopoulos et al. 2005), so 
that the transgene product accumulates more quickly and is detectable earlier on. The RNA export 
function of WPRE involves in a cellular factor CRM-1, an export receptor for leucine-rich nuclear 
export signals (Fornerod et al. 1997; Popa et al. 2002). A deficiency in this factor may explain the 
negative effects of WPRE observed in some cases (Werner et al. 2004; Klein et al. 2006). In 
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Xenopus, the CRM-1 factor is present during the early stage of embryogenesis and becomes 
functional before the neurulation (Callanan et al. 2000). 
The efficiency of the association between the xneuroD promoter and WPRE was first assessed by 
transfection studies in the pluripotent P19 embryonal carcinoma cells that can differentiate in 
neuronal cells upon a retinoic acid treatment. The difference in the activities observed with the two 
promoter fragments used can be explained by the presence of a potential binding site for the 
transcriptional repressor IA-1 in the 1.3neuroD fragment (Breslin et al. 2002).  The addition of 
WPRE significantly increased the reporter gene expression with both promoter fragments. Our 
results are close to the 1.5-fold induction in RNA or protein levels obtain in a plasmid vector 
context when this vector is stably integrated in the host cells (Johansen et al. 2003). Using 
adenoviral vector, Glover et al. (2002) also reported a similar elevation with the SYN1 promoter 
which drives a neuron-specific expression. Other studies reported higher elevations. However, these 
works were based on the use of retroviral or lentiviral vectors and strong promoters such as CMV 
(cytomegalovirus) or MMTV (mouse mammary tumour virus) promoters (Zufferey et al. 1999; 
Klein et al. 2006). 
The ability of WPRE to promote gene expression was then evaluated in vivo in transgenic Xenopus 
embryos. Addition of this element in the plasmid vector used for transgenesis increased the reporter 
gene expression driven by the 0.3neuroD promoter and allowed an earlier detection of EGFP in 
more embryos (63%) without modifying the localization in the nervous system. This improvement 
in the detection of transgene expression was notably observed with the 1.3neuroD promoter 
fragment. The enhancement of reporter expression, due to the improvement of the transgenic 
technique and the addition of the WPRE element, permitted an early detection (stage 15) of EGFP 
controlled by Xenopus neuroD promoter, which occurs slightly later than the appearance of neuroD 
mRNA at stage 13.5/14 (Lee et al. 1995; Ma et al. 1996). Transgene expression with p0.3neuroD-
EGFP-WPRE was found to be specifically localized in the developing nervous system, in structures 
in which neuroD mRNA was detected (Lee et al. 1995; Ma et al. 1996; Huang et al. 2000; Schlosser 
17 
 
and Northcutt 2000; Schlosser et al. 2002). This concordance was maintained at later stage. Indeed, 
at stage 48, confocal microscopy imaging as well as in situ hybridisation studies allowed the 
detection of EGFP in limited areas corresponding to neuroD-expressing brain areas during 
neurogenesis in Xenopus (Wullimann et al. 2005). 
Thus, in this study, we describe a transgenesis method that allows the production of fully transgenic 
F0 animals with a limited number of insertion events. Moreover, we show that regulatory elements 
such as WRPE can be successfully used to improve transgene expression in Xenopus making 
possible the use of a promoter with low activity to label a group of cells or a particular tissue. 
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Figure legends  
 
Fig. 1 In vivo Expression of the NTub-EGFP transgene co-injected with I-SceI meganuclease 
and sperm nuclei into X. laevis oocytes 
Fluorescence can be detected in the neural tube at stage 18 (A), the brain and spinal cord at stage 34 
(B) or 46 (C), the brain, retina and cranial nerves such as optic or olfactory nerves at stage 55 (D). 
The innervation of the tail myotomes (E) and hind limbs (F) is also easily detectable (NT: neural 
tube; B: brain; SC: spinal cord; Olf: olfactory nerve; Opt: optic nerve). Scale bar: (A) 500 µm; 
(B,C) 1 mm; (D,E,F) 2 mm. 
 
Fig. 2 Activation of XneuroD promoter fragments in P19 cells 
(A) P19 cells were transfected with pGL3, p0.3neuroD-Luc or p1.3neuroD-Luc constructs. NeuroD 
promoter fragments activities were assayed with pCS2-X-Ngnr-1a (+NGN) cotransfection. 
Activities were normalized to that of pGL3. (B) Effect of the WPRE element addition in the 
reporter constructs was assessed. Data represent relative luciferase activity obtained 45 hours after 
transfection and normalized to -Galactosidase activity, expressed from a cotransfected control 
plasmid. Each activity is the mean ± SEM of at least four independent experiments with triplicate 
transfections (A and B). 
 
Fig. 3 Confocal microscopy images of EGFP expression in live transgenic F1 embryos 
obtained with p0.3neuroD-EGFP-WPRE construct 
(A) EGFP fluorescence was found in the retina and the five embryonic brain vesicles of stage 40-41 
(Tel: Telencephalon, Di: Diencephalon, Mes: Mesencephalon, Met: Metencephalon, Myel: 
Myelencephalon, Ret: Retina). (B) In vivo spatial expression of EGFP fluorescence in the whole 
brain of a stage 48 embryo. (Pa: pallium, OT: Optic Tectum, C: Cerebellum, Rho: 
Rhombencephale); Scale bar: 100 µm 
 
Fig. 4 In situ hybridisation analysis of xNeuroD and EGFP expression in transgenic 
0.3NeuroD-EGFP-WPRE larva (stage 48) 
Consecutive transverse sections at the level of cerebellum (A,B) and rhombencephalon (C,D) were 
hybridized with the xNeuroD (A,C) and EGFP (B,D) probes. Dorsal is to the top. Arrow indicates 
the position of a ganglion of the cranial nerve IX. Scale bar: 100 µm 
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Fig. 5 PCR and Southern blot analysis on genomic DNA from 0.3neuroD-EGFP-WPRE 
animals 
(A) Genomic PCR of F1 siblings from a 0.3neuroD-EGFP-WPRE founder. Lanes labeled (-) or (+) 
represent genomic DNA from individual EGFP-negative or EGFP-positive tadpoles respectively. 
Wt is a control performed on wild-type genomic DNA. M: DNA ladder (B) Schematic 
representation of the transgene with the relative position of the probe and restriction sites. Below, 
products expected after transgene integration according to the different possibilities of 
concatemerization. (C) Southern blot analysis of F1 progeny. DNA from EGFP-positive tadpoles 
was digested by either BsrG I (lane1) or Bam HI (lane 2). DNA from EGFP-negative tadpoles was 
digested by BsrG I (lane3). 
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Plasmid Injected eggs surviving embryos 
at stage 40
% of EGFP expressing embryos at stage 40
SNC specific Hemi body
SNC and 
other tissues
Ectopic None
pSce-NbTub-EGFP-
Sce
5588 142 29 0.7 26 7 37
Table 1 : Transgenesis efficiency for the N Tub-EGFP construct
Table 2 : Germline transmission of the N Tub -EGFP transgene
Fo founder EGFP+ embryos / 
total F1 embryos
Transmission 
rate (%)
EGFP+ embryos / 
total F2 embryos
Transmission rate 
(%)
pN Tub-EGFP #1 0/59 0
pN Tub-EGFP #2 585/1167 48 255/534 47.53
pN Tub-EGFP #3 270/529 51
pN Tub-EGFP #4 213/365 58
pN Tub-EGFP #5 52/98 53
pN Tub-EGFP #6 403/790 51
pN Tub-EGFP #7 418/589 71
Plasmids Injected eggs
% of embryos expressing EGFP in the developing nervous system % of surviving 
embryos at stage 40
stage 15 stages 18/20 stage 33 stage 40
0.3NeuroD-EGFP 2250 0 (0/69) 9 (6/69) 21 (11/52) 18 (6/34) 1.5
0.3NeuroD-EGFP-WPRE 1357 19 (16/83) 35 (29/83) 48 (30/62) 63 (32/51) 3.75
1.3NeuroD-EGFP 1181 0 (0/18) 0 (0/18) 0 (0/16) 0 (0/2) 0.17
1.3NeuroD-EGFP-WPRE 1647 0 (0/39) 0 (0/39) 7 (2/27) 25 (2/8) 0.5
Table 3 : EGFP fluorescence driven by xneuroD promoter fragments at different stages of development
Table 4 : Germline transmission of the 0.3neuroD-EGFP-WPRE transgene
Fo founder
EGFP+ embryos / 
total F1 embryos
Transmission 
rate (%)
EGFP+ embryos / 
total F2 embryos
Transmission 
rate (%)
p0.3NeuroD-EGFP-WPRE #1 119/310 46
p0.3NeuroD-EGFP-WPRE #2 115/125 92
p0.3NeuroD-EGFP-WPRE #3 604/1137 53 96/189 51
p0.3NeuroD-EGFP-WPRE #4 549/1173 47
p0.3NeuroD-EGFP-WPRE #5 21/49 43
p0.3NeuroD-EGFP-WPRE #6 42/104 40
